1月12日,齐鲁制药旗下1.1类创新药、ALK阳性非小细胞肺癌靶向治疗新药——启欣可®(伊鲁阿克片)在京东健康全网首发。该药物的上市,进一步丰富了京东健康在肺癌精准治疗领域的产品矩阵,为更多ALK阳性肺癌患者提供了全新的治疗选择。京东健康将持续发挥“新特药全网首发第一站”的能力优势,推动更多前沿治疗药物快速触达患者,提升药品可及性与治疗规范性。肺癌是我国发病率和死亡率最高的恶性肿瘤,其中非小细胞...
Source Link1月12日,齐鲁制药旗下1.1类创新药、ALK阳性非小细胞肺癌靶向治疗新药——启欣可®(伊鲁阿克片)在京东健康全网首发。该药物的上市,进一步丰富了京东健康在肺癌精准治疗领域的产品矩阵,为更多ALK阳性肺癌患者提供了全新的治疗选择。京东健康将持续发挥“新特药全网首发第一站”的能力优势,推动更多前沿治疗药物快速触达患者,提升药品可及性与治疗规范性。肺癌是我国发病率和死亡率最高的恶性肿瘤,其中非小细胞...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.